Jeffrey W Sherman Horizon Therapeutics Public LTD CO (HZNP) insider trading activity

Jeffrey W Sherman is EVP and Chief Medical Officer of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 0 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2021, when has been sold 5,287 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

JEFFREY W SHERMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2021	BUY Bona fide gift	-	5,287 Added 9.18%	52,276 Ordinary Shares
May 25 2021	SELL Bona fide gift	-	12,304 Reduced 20.75%	46,989 Ordinary Shares
Mar 10 2021	SELL Bona fide gift	-	66,730 Reduced 82.25%	14,402 Ordinary Shares
Feb 17 2021	SELL Payment of exercise price or tax liability	$75,925 $87.17 p/Share	871 Reduced 1.08%	80,083 Ordinary Shares
Feb 17 2021	BUY Grant, award, or other acquisition	-	1,965 Added 2.37%	80,954 Ordinary Shares
Jan 21 2021	SELL Payment of exercise price or tax liability	$183,664 $77.43 p/Share	2,372 Reduced 2.92%	78,989 Ordinary Shares
Jan 21 2021	BUY Exercise of conversion of derivative security	-	5,353 Added 6.17%	81,361 Ordinary Shares
Jan 05 2021	SELL Payment of exercise price or tax liability	$3,316,360 $73.28 p/Share	45,256 Reduced 34.83%	84,687 Ordinary Shares
Jan 05 2021	BUY Grant, award, or other acquisition	-	60,313 Added 31.7%	129,943 Ordinary Shares
Jan 05 2021	BUY Exercise of conversion of derivative security	-	41,615 Added 37.41%	69,630 Ordinary Shares
Dec 29 2020	SELL Bona fide gift	-	8,679 Reduced 10.25%	76,008 Ordinary Shares
Oct 21 2020	BUY Exercise of conversion of derivative security	$98,930 $7.61 p/Share	13,000 Added 31.7%	28,015 Ordinary Shares
May 11 2020	SELL Open market or private sale	$1,506,555 $45.0 p/Share	33,479 Reduced 70.56%	13,966 Ordinary Shares
May 11 2020	BUY Exercise of conversion of derivative security	$166,056 $4.96 p/Share	33,479 Added 41.37%	47,445 Ordinary Shares
Mar 11 2020	BUY Exercise of conversion of derivative security	$68,414 $12.94 p/Share	5,287 Added 27.46%	13,966 Ordinary Shares
Mar 23 2018	SELL Payment of exercise price or tax liability	$118,198 $13.86 p/Share	8,528 Reduced 3.86%	212,341 Ordinary Shares
Mar 23 2018	BUY Exercise of conversion of derivative security	-	19,250 Added 8.02%	220,869 Ordinary Shares
Jan 02 2018	SELL Payment of exercise price or tax liability	$115,354 $15.02 p/Share	7,680 Reduced 3.67%	201,619 Ordinary Shares
Jan 02 2018	BUY Exercise of conversion of derivative security	-	15,500 Added 6.9%	209,299 Ordinary Shares
Mar 23 2017	SELL Payment of exercise price or tax liability	$128,099 $14.56 p/Share	8,798 Reduced 4.37%	192,350 Ordinary Shares
Mar 23 2017	BUY Exercise of conversion of derivative security	-	19,250 Added 8.73%	201,148 Ordinary Shares
Jan 02 2017	SELL Payment of exercise price or tax liability	$203,900 $16.18 p/Share	12,602 Reduced 6.48%	181,898 Ordinary Shares
Jan 02 2017	BUY Exercise of conversion of derivative security	-	26,750 Added 12.09%	194,500 Ordinary Shares
Dec 16 2016	BUY Exercise of conversion of derivative security	$20,400 $2.4 p/Share	8,500 Added 4.82%	167,750 Ordinary Shares
Aug 02 2016	SELL Open market or private sale	$58,000 $20.0 p/Share	2,900 Reduced 1.79%	159,250 Ordinary Shares

Also insider at

SBBP

Strongbridge Biopharma plc

Director

XERS

XERIS PHARMACEUTICALS INC Healthcare

Director

XERS

Xeris Biopharma Holdings, Inc. Healthcare

Director

LRMR

Larimar Therapeutics, Inc. Healthcare

Director

JWS